Evaluation of lipoprotein-associated phospholipase A2 levels in association with carotid atherosclerosis in patients with coronary artery disease

被引：0
|
作者：
Osmankulova, G. [1 ]
Kurmanbekova, B. T. [1 ]
Noruzbaeva, A. M. [1 ]
机构：
[1] Natl Ctr Cardiol & Therapy, Bishkek, Kyrgyzstan
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P893
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [21] Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis
    Vickers, Kasey C.
    Maguire, Colin T.
    Wolfert, Robert
    Burns, Alan R.
    Reardon, Michael
    Geis, Richard
    Holvoet, Paul
    Morrisett, Joel D.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (09) : 1735 - 1743
  • [22] Lipoprotein-associated Phospholipase A2 is Associated with Angiographic Coronary Artery Disease and Coronary Artery Risk Factors in the Elderly
    Dong, Lini
    Qu, Xiaobing
    Hu, Zhi Gao
    Peng, Xiaoli
    Wang, Yanjiao
    Miao, Qin
    Zhang, Xiangyu
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2015, 9 (02) : 82 - 86
  • [23] Lipoprotein-associated phospholipase A2 as independent predictor of atherosclerosis among patients with zero coronary artery calcium score
    Kaczmarska, E.
    Dzielinska, Z.
    Kepka, C.
    Janas, J.
    Kunicki, P.
    Kryczka, K.
    Pracon, R.
    Kruk, M.
    Pregowski, J.
    Demkow, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 811 - 811
  • [24] Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
    Muriel J Caslake
    Chris J Packard
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 529 - 535
  • [25] Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
    Caslake, MJ
    Packard, CJ
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (10): : 529 - 535
  • [26] Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease
    Horne, BD
    Anderson, JL
    Wolfert, RL
    Muhlestein, JB
    Renlund, DG
    Clarke, JL
    Thomas, H
    Kolek, MJ
    Bair, TL
    Pearson, RR
    Sudhir, K
    Cariquist, JF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 224A - 224A
  • [27] Elevated plasma lipoprotein-associated phospholipase A2 activity is associated with plaque rupture in patients with coronary artery disease
    Liu Chuan-fen
    Qin Li
    Ren Jing-yi
    Chen Hong
    Wang Wei-min
    Liu Jian
    Song Jun-xian
    Li Li-jun
    CHINESE MEDICAL JOURNAL, 2011, 124 (16) : 2469 - 2473
  • [28] Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease
    Sabatine, Marc S.
    Morrow, David A.
    O'Donoghue, Michelle
    Jablonksi, Kathleen A.
    Rice, Madeline Murguia
    Solomon, Scott
    Rosenberg, Yves
    Domanski, Michael J.
    Hsia, Judith
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (11) : 2463 - 2469
  • [29] SERUM LEVELS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Petrkova, J.
    Navratilova, Z.
    Petrek, M.
    Martin, P.
    ATHEROSCLEROSIS, 2015, 241 (01) : E186 - E186
  • [30] Lipoprotein-associated phospholipase A2 is especially predictive of coronary artery disease among patients with the metabolic syndrome
    Lavasani, Farangis
    May, Heidi T.
    Horne, Benjamin D.
    Anderson, Jeffrey L.
    Carlquist, John F.
    Wolfert, Robert L.
    Pearson, Robert R.
    Lanman, Richard B.
    Muhlestein, Joseph B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 339A - 339A
12345